Matches in SemOpenAlex for { <https://semopenalex.org/work/W2161167771> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W2161167771 startingPage "3329" @default.
- W2161167771 abstract "Background Abediterol (LAS100977) is a novel, once-daily, LABA in development for the treatment of asthma and COPD. We investigated the PK and pharmaceutical interaction of mometasone furoate (inhaled corticosteroid) in combination with abediterol in healthy subjects.Methods In this Phase I, 4-way crossover study, healthy subjects were randomised to single doses of: fixed-dose combination (FDC) abediterol/mometasone 0.625/340 µg and 2.5/340 µg; free-dose combination abediterol+mometasone 2.5/340 µg; or mometasone 340 µg alone, via Genuair®/Pressair™, with ≥10-days washout. Endpoints included 36-hour PK parameters and safety and tolerability.Results 24/28 subjects completed the study (N=22 male, mean age 33.0 years [SD±7.0]). Mometasone disposition kinetics were similar across all treatments; tmax: 1.7 – 2.3 hours; t½: 8.5 – 9.4 hours. Abediterol tmax was achieved within 30 minutes (all treatments). Estimated t½ for abediterol 2.5 µg: 23.8 hours (FDC); 24.3 hours (free-dose). See table for PK parameter comparisons. All treatments were safe and well tolerated; the most common treatment-emergent adverse events were headache (14%), myalgia (11%), diarrhoea, nausea, vomiting and anxiety (each 7%).Conclusion Abediterol and mometasone co-administration (FDC or free-dose) has minimal impact on PK parameters of either drug within predicted therapeutic dose ranges.![Figure][1] [1]: pending:yes" @default.
- W2161167771 created "2016-06-24" @default.
- W2161167771 creator A5009588067 @default.
- W2161167771 creator A5014141473 @default.
- W2161167771 creator A5014714297 @default.
- W2161167771 creator A5032370294 @default.
- W2161167771 creator A5042080166 @default.
- W2161167771 creator A5063650460 @default.
- W2161167771 creator A5073147327 @default.
- W2161167771 date "2014-09-01" @default.
- W2161167771 modified "2023-09-26" @default.
- W2161167771 title "Pharmacokinetics (PK), safety and tolerability of abediterol and mometasone furoate fixed- and free-dose combinations in healthy subjects" @default.
- W2161167771 hasPublicationYear "2014" @default.
- W2161167771 type Work @default.
- W2161167771 sameAs 2161167771 @default.
- W2161167771 citedByCount "0" @default.
- W2161167771 crossrefType "journal-article" @default.
- W2161167771 hasAuthorship W2161167771A5009588067 @default.
- W2161167771 hasAuthorship W2161167771A5014141473 @default.
- W2161167771 hasAuthorship W2161167771A5014714297 @default.
- W2161167771 hasAuthorship W2161167771A5032370294 @default.
- W2161167771 hasAuthorship W2161167771A5042080166 @default.
- W2161167771 hasAuthorship W2161167771A5063650460 @default.
- W2161167771 hasAuthorship W2161167771A5073147327 @default.
- W2161167771 hasConcept C112705442 @default.
- W2161167771 hasConcept C126322002 @default.
- W2161167771 hasConcept C142724271 @default.
- W2161167771 hasConcept C197934379 @default.
- W2161167771 hasConcept C204787440 @default.
- W2161167771 hasConcept C27081682 @default.
- W2161167771 hasConcept C2776623344 @default.
- W2161167771 hasConcept C2776804153 @default.
- W2161167771 hasConcept C2778375690 @default.
- W2161167771 hasConcept C2780580376 @default.
- W2161167771 hasConcept C2780852908 @default.
- W2161167771 hasConcept C2781348165 @default.
- W2161167771 hasConcept C42219234 @default.
- W2161167771 hasConcept C71924100 @default.
- W2161167771 hasConcept C87813604 @default.
- W2161167771 hasConcept C98274493 @default.
- W2161167771 hasConceptScore W2161167771C112705442 @default.
- W2161167771 hasConceptScore W2161167771C126322002 @default.
- W2161167771 hasConceptScore W2161167771C142724271 @default.
- W2161167771 hasConceptScore W2161167771C197934379 @default.
- W2161167771 hasConceptScore W2161167771C204787440 @default.
- W2161167771 hasConceptScore W2161167771C27081682 @default.
- W2161167771 hasConceptScore W2161167771C2776623344 @default.
- W2161167771 hasConceptScore W2161167771C2776804153 @default.
- W2161167771 hasConceptScore W2161167771C2778375690 @default.
- W2161167771 hasConceptScore W2161167771C2780580376 @default.
- W2161167771 hasConceptScore W2161167771C2780852908 @default.
- W2161167771 hasConceptScore W2161167771C2781348165 @default.
- W2161167771 hasConceptScore W2161167771C42219234 @default.
- W2161167771 hasConceptScore W2161167771C71924100 @default.
- W2161167771 hasConceptScore W2161167771C87813604 @default.
- W2161167771 hasConceptScore W2161167771C98274493 @default.
- W2161167771 hasLocation W21611677711 @default.
- W2161167771 hasOpenAccess W2161167771 @default.
- W2161167771 hasPrimaryLocation W21611677711 @default.
- W2161167771 hasRelatedWork W1528667565 @default.
- W2161167771 hasRelatedWork W1874347560 @default.
- W2161167771 hasRelatedWork W1988236899 @default.
- W2161167771 hasRelatedWork W2236129730 @default.
- W2161167771 hasRelatedWork W2757136007 @default.
- W2161167771 hasRelatedWork W2772874366 @default.
- W2161167771 hasRelatedWork W2779189585 @default.
- W2161167771 hasRelatedWork W2789880064 @default.
- W2161167771 hasRelatedWork W2800030773 @default.
- W2161167771 hasRelatedWork W2896365094 @default.
- W2161167771 hasRelatedWork W2897213984 @default.
- W2161167771 hasRelatedWork W2944524197 @default.
- W2161167771 hasRelatedWork W3010648955 @default.
- W2161167771 hasRelatedWork W3101234883 @default.
- W2161167771 hasRelatedWork W3125953195 @default.
- W2161167771 hasRelatedWork W3129445326 @default.
- W2161167771 hasRelatedWork W3139512702 @default.
- W2161167771 hasRelatedWork W3157983311 @default.
- W2161167771 hasRelatedWork W3186611466 @default.
- W2161167771 hasRelatedWork W2938293580 @default.
- W2161167771 hasVolume "44" @default.
- W2161167771 isParatext "false" @default.
- W2161167771 isRetracted "false" @default.
- W2161167771 magId "2161167771" @default.
- W2161167771 workType "article" @default.